PMID- 30078651 OWN - NLM STAT- MEDLINE DCOM- 20190314 LR - 20190314 IS - 1875-2128 (Electronic) IS - 1875-2128 (Linking) VI - 111 IP - 12 DP - 2018 Dec TI - Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation. PG - 758-765 LID - S1875-2136(18)30102-5 [pii] LID - 10.1016/j.acvd.2018.05.004 [doi] AB - BACKGROUND: The frequency, characteristics and outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients who eventually undergo heart transplantation (HT) during follow-up have not been well described. AIMS: In a cohort of patients with heart failure implanted with an ICD for primary prevention of sudden cardiac death, to identify those at high risk of subsequent HT and evaluate ICD usefulness. METHODS: Between 2002 and 2012, 5539 patients received a primary prevention ICD across 12 centers, and were enrolled in the DAI-PP programme, including 5427 with full HT information available. RESULTS: During a median follow-up of 1024 days (interquartile range 484-1702 days), 176 (3.2%) patients underwent HT. Median duration between ICD implantation and HT was 484 days (IQR 169-1117 days). Among those aged